Related Experiment Video
Updated: Feb 3, 2026

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
Published on: May 1, 2019
Immunotherapy for gastric cancer: dilemmas and prospect
Qingfang Zhao1, Liang Cao2, Lulu Guan1
1Zhengzhou University, Zhengzhou, China.
Abstract:
Gastric cancer remains the second most common cause of cancer-related death worldwide. Because of the poor prognosis of late-stage gastric cancer patients, it is imperative to develop new strategies to improve the survival rate of this disease. Currently, immunotherapy is considered as an innovative approach for cancers such as lung cancer, gastric cancer and breast cancer. In fact, previous works have revealed promising results in this field. With further understanding of immunogenomics of gastric cancer, new immune checkpoint regulators could become more important. In addition, whole-genome sequencing and genome editing provide us with more information on the heterogeneity of gastric cancer, showing helpful tools to identify new predictive biomarkers and to achieve personalized treatment. Further research and better understanding of the functions of immune system will enhance immunotherapy treatment in the future.
Insights
Gastric cancer immunotherapy shows promise for improving survival rates. Further research into immunogenomics and personalized treatments is crucial for advancing gastric cancer care.
Area of Science:
- Oncology
- Immunology
Background:
- Gastric cancer is a leading cause of cancer mortality globally.
- Late-stage gastric cancer has a poor prognosis, necessitating novel therapeutic strategies.
- Immunotherapy is an emerging and promising treatment modality for various cancers, including gastric cancer.
Purpose of the Study:
- To highlight the potential of immunotherapy in improving gastric cancer patient survival.
- To emphasize the importance of immunogenomics in identifying new therapeutic targets.
- To underscore the role of genomic technologies in personalized gastric cancer treatment.
Main Methods:
- Review of current research on gastric cancer immunotherapy.
- Exploration of immunogenomic data and its implications.
- Discussion of whole-genome sequencing and genome editing applications.
Main Results:
- Immunotherapy has demonstrated promising results in preclinical and clinical studies for gastric cancer.
- Understanding gastric cancer immunogenomics can reveal novel immune checkpoint regulators.
- Genomic technologies offer tools for identifying predictive biomarkers and enabling personalized medicine.
Conclusions:
- Advancing the understanding of the immune system's role is key to enhancing gastric cancer immunotherapy.
- Personalized treatment strategies based on genomic insights hold significant potential.
- Continued research is vital for optimizing immunotherapy efficacy in gastric cancer.
Related Concept Videos
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Dilemmas II
Tumor Immunotherapy
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying
Gastric Phase of Digestion
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...

